C. Bulaï Livideanu

2.7k total citations
81 papers, 824 citations indexed

About

C. Bulaï Livideanu is a scholar working on Immunology, Rheumatology and Dermatology. According to data from OpenAlex, C. Bulaï Livideanu has authored 81 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Immunology, 27 papers in Rheumatology and 26 papers in Dermatology. Recurrent topics in C. Bulaï Livideanu's work include Mast cells and histamine (26 papers), Urticaria and Related Conditions (17 papers) and Psoriasis: Treatment and Pathogenesis (12 papers). C. Bulaï Livideanu is often cited by papers focused on Mast cells and histamine (26 papers), Urticaria and Related Conditions (17 papers) and Psoriasis: Treatment and Pathogenesis (12 papers). C. Bulaï Livideanu collaborates with scholars based in France, United States and Belgium. C. Bulaï Livideanu's co-authors include C. Paul, Olivier Hermine, F. Giordano‐Labadie, R. Viraben, Nicolás Meyer, Patrice Dubreuil, J. Mazereeuw‐Hautier, Yannick Degboé, Laurence Lamant and Katia Hanssens and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Allergy and Clinical Immunology.

In The Last Decade

C. Bulaï Livideanu

69 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Bulaï Livideanu France 17 387 299 245 159 135 81 824
Yuichi Teraki Japan 19 335 0.9× 296 1.0× 394 1.6× 237 1.5× 61 0.5× 46 950
Igor Snast Israel 11 158 0.4× 148 0.5× 271 1.1× 102 0.6× 82 0.6× 41 555
Sophie Hugot Switzerland 9 1.0k 2.6× 378 1.3× 577 2.4× 221 1.4× 49 0.4× 10 1.3k
Martina Burlando Italy 16 460 1.2× 252 0.8× 357 1.5× 227 1.4× 98 0.7× 96 859
Kara N. Shah United States 14 434 1.1× 174 0.6× 291 1.2× 118 0.7× 18 0.1× 28 860
Rosemarie M. Watson United States 14 315 0.8× 438 1.5× 258 1.1× 101 0.6× 17 0.1× 16 902
É. Bégon France 14 292 0.8× 157 0.5× 297 1.2× 160 1.0× 45 0.3× 49 714
Vimal H. Prajapati Canada 13 249 0.6× 179 0.6× 588 2.4× 89 0.6× 18 0.1× 87 861
A. Maza France 11 297 0.8× 129 0.4× 212 0.9× 158 1.0× 46 0.3× 24 593
Mukaddes Kavala Türkiye 12 113 0.3× 243 0.8× 161 0.7× 198 1.2× 85 0.6× 53 554

Countries citing papers authored by C. Bulaï Livideanu

Since Specialization
Citations

This map shows the geographic impact of C. Bulaï Livideanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Bulaï Livideanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Bulaï Livideanu more than expected).

Fields of papers citing papers by C. Bulaï Livideanu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Bulaï Livideanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Bulaï Livideanu. The network helps show where C. Bulaï Livideanu may publish in the future.

Co-authorship network of co-authors of C. Bulaï Livideanu

This figure shows the co-authorship network connecting the top 25 collaborators of C. Bulaï Livideanu. A scholar is included among the top collaborators of C. Bulaï Livideanu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Bulaï Livideanu. C. Bulaï Livideanu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Degboé, Yannick, et al.. (2025). Management of Bone Health in Adult Mastocytosis. Current Osteoporosis Reports. 23(1). 10–10. 3 indexed citations
2.
Castells, Mariana, C. Bulaï Livideanu, Olivier Hermine, et al.. (2025). HARBOR: An Ongoing Phase 2/3 Study of Elenestinib in Patients With Indolent Systemic Mastocytosis. Journal of Allergy and Clinical Immunology. 155(2). AB170–AB170. 1 indexed citations
3.
Livideanu, C. Bulaï, et al.. (2024). Clinical and biological characteristics associated with bronchial or pulmonary abnormalities on chest CT imaging in patients with systemic mastocytosis. Clinical and Translational Allergy. 14(8). e12387–e12387. 2 indexed citations
4.
Degboé, Yannick, P.A. Apoil, Nicolas Gaudenzio, et al.. (2024). The Prevalence Of Osteoporosis Is Low in Adult Cutaneous Mastocytosis Patients. The Journal of Allergy and Clinical Immunology In Practice. 12(5). 1306–1312. 2 indexed citations
5.
Chasset, François, Alexis Mathian, Noémie Abisror, et al.. (2023). Rapid efficacy of anifrolumab in refractory cutaneous lupus erythematosus. Journal of the American Academy of Dermatology. 89(1). 171–173. 24 indexed citations
6.
Ogbogu, Princess U., C. Bulaï Livideanu, Paul Van Daele, et al.. (2023). AVAPRITINIB IMPROVED GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS: REGISTRATIONAL DOUBLE-BLIND, PLACEBO-CONTROLLED PIONEER STUDY. Annals of Allergy Asthma & Immunology. 131(5). S81–S81. 1 indexed citations
7.
Houmadi, Raïssa, Nadine Serhan, M. Tauber, et al.. (2023). 3D deconvolution of human skin immune architecture with Multiplex Annotated Tissue Imaging System. Science Advances. 9(23). eadf9491–eadf9491. 6 indexed citations
8.
Livideanu, C. Bulaï, P.A. Apoil, Benoît Lepage, et al.. (2021). Apport de la cytométrie de flux médullaire pour le diagnostic de mastocytose systémique. 1(8). A144–A145.
9.
Gaudenzio, Nicolas, et al.. (2020). Omalizumab in the treatment of adult patients with mastocytosis: A systematic review. Clinical & Experimental Allergy. 50(6). 654–661. 47 indexed citations
10.
Degboé, Yannick, P.A. Apoil, C. Mailhol, et al.. (2019). Higher prevalence of vertebral fractures in systemic mastocytosis, but not in cutaneous mastocytosis and idiopathic mast cell activation syndrome. Osteoporosis International. 30(6). 1235–1241. 11 indexed citations
11.
Livideanu, C. Bulaï, et al.. (2019). Infection à CMV et syndrome de Guillain–Barré associés à un traitement par sécukinumab. Annales de Dermatologie et de Vénéréologie. 146(12). A314–A314.
12.
Lemal, Richard, Guillemette Fouquet, Louis Terriou, et al.. (2019). Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS. The Journal of Allergy and Clinical Immunology In Practice. 7(7). 2387–2395.e3. 39 indexed citations
13.
Tauber, M., et al.. (2018). Compounded topical preparations in plaque psoriasis: Still a place for it in 2018?. Dermatologic Therapy. 32(1). e12780–e12780.
14.
Silva, Geisilene Russano de Paiva, É. Tournier, Luı́s Otávio Sarian, et al.. (2018). Prevalence of CD30 immunostaining in neoplastic mast cells. Medicine. 97(21). e10642–e10642. 9 indexed citations
15.
Mahé, E., F. Maccari, Alain Beauchet, et al.. (2017). Patients atteints de psoriasis : analyse de la population insatisfaite de sa prise en charge. Annales de Dermatologie et de Vénéréologie. 144(8-9). 497–507. 2 indexed citations
16.
Regnault, M. Masson, A. Khemis, Marc Bourcier, et al.. (2016). Dynamique de rechute du psoriasis à l’arrêt du brodalumab (Ac anti IL-17RA) : étude rétrospective, multicentrique chez 77 patients. Annales de Dermatologie et de Vénéréologie. 143(12). S137–S137.
17.
18.
Livideanu, C. Bulaï, et al.. (2011). Cytophagic Histiocytic Panniculitis after H1N1 Vaccination: A Case Report and Review of the Cutaneous Side Effects of Influenza Vaccines. Dermatology. 222(3). 217–220. 2 indexed citations
19.
Livideanu, C. Bulaï, F. Giordano‐Labadie, & C. Paul. (2007). Cellular phone addiction and allergic contact dermatitis to nickel. Contact Dermatitis. 57(2). 130–131. 28 indexed citations
20.
Livideanu, C. Bulaï, et al.. (2006). Pyoderma gangrenosum as initial manifestation of Graves' disease. Clinical and Experimental Dermatology. 31(5). 659–661. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuichi Teraki Breakdown of academic impact, for papers by Igor Snast Breakdown of academic impact, for papers by Sophie Hugot Breakdown of academic impact, for papers by Martina Burlando Breakdown of academic impact, for papers by Kara N. Shah Breakdown of academic impact, for papers by Rosemarie M. Watson Breakdown of academic impact, for papers by É. Bégon Breakdown of academic impact, for papers by Vimal H. Prajapati Breakdown of academic impact, for papers by A. Maza Breakdown of academic impact, for papers by Mukaddes Kavala
Rankless by CCL
2026